JPRN-jRCT2080223171
Unknown
Phase 1
A Phase I Study to Assess the Safety and Immunogenicity of DNK-651 in Japanese Healthy Young Adults and Elderly Adults
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- DENKA SEIKEN CO.,LTD.
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy Young Adults(20\-40\) and Elderly Adults(65\-)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Malaria vectored vaccines and EPI co-administration trial (VAC 058)PACTR201402000749217THE JENNER INSTITUTE, UNIVERSITY OF OXFORD65
Active, Not Recruiting
Phase 1
Investigating a vaccine against plaguePlagueInfections and InfestationsISRCTN41077863niversity of Oxford36
Active, Not Recruiting
Phase 1
A first-in-human study to assess the safety of an MVA-based vaccine for Crimean-Congo Haemorrhagic Fever (MVA-CCHF) and the vaccine's ability to generate an immune responseCrimean-Congo Haemorrhagic FeverInfections and InfestationsISRCTN14935155niversity Hospital Southampton NHS Foundation Trust18
Completed
Phase 1
Safety and immunogenicity of a new tuberculosis (TB) vaccine (MVA85A) in healthy volunteers in Cape TowISRCTN17498868niversity of Oxford (UK)36
Active, Not Recruiting
Phase 1
A clinical trial to assess the safety, immune response, and protection against infection of novel malaria vaccines.Plasmodium falciparum infectionTherapeutic area: Diseases [C] - Parasitic Diseases [C03]EUCTR2017-001049-28-GBniversity of Oxford, CTRG18